Wayne H. Pinover

Thomas Jefferson University — United States

Medicine · Health Sciences

26h-index3.3kcitations73works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(40), Prostate Cancer Treatment and Research(36), Advanced Radiotherapy Techniques(32), Medical Imaging Techniques and Applications(6), Colorectal and Anal Carcinomas(5)

Publications73 total

PO29
Brachytherapy·2023
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Journal of Clinical Oncology·2020· 274 citedOpen Access
RADI-04. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933
Neuro-Oncology Advances·2019Open Access
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2018· 73 citedOpen Access
A rare case of primary pulmonary angiosarcoma
Journal of Case Reports and Images in Oncology·2018· 1 citedOpen Access
NCOG-02. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933
Neuro-Oncology·2017Open Access
Abstract LB-240: Circulating tumor cell (CTC) analysis in NRG oncology/RTOG 1014, repeat breast conserving treatment after in-breast recurrence (IBR)
Cancer Research·2017
Investigation Into the Feasibility of Having Uniform Compliance Dosimetric Criteria Across Radiation Therapy Treatment Modalities for NRG Oncology/RTOG 0938 by Using Machine Learning
International Journal of Radiation Oncology*Biology*Physics·2016Open Access
Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP).
Journal of Clinical Oncology·2016· 3 cited
Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2015· 21 cited
Evaluation of Planned Treatment Breaks During Radiation Therapy for Anal Cancer: Update of RTOG 92-08
International Journal of Radiation Oncology*Biology*Physics·2008· 120 citedOpen Access
Psychoeducational group intervention for wives of men with prostate cancer
Psycho-Oncology·2003· 123 cited
Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination
Urology·2003· 29 cited
Validation of a treatment policy for patients with prostate specific antigen failure after three‐dimensional conformal prostate radiation therapy
Cancer·2003· 70 cited
Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants
Radiotherapy and Oncology·2003· 17 cited
Late morbidity profiles in prostate cancer patients treated to 79–84 Gy by a simple four-field coplanar beam arrangement
International Journal of Radiation Oncology*Biology*Physics·2002· 74 cited
Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapy
International Journal of Radiation Oncology*Biology*Physics·2002· 7 cited
Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method
International Journal of Radiation Oncology*Biology*Physics·2002· 21 cited
Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control
International Journal of Radiation Oncology*Biology*Physics·2002· 19 cited
Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
PubMed·2002· 14 cited
page 1 of 4Next →

Frequent Co-authors

Gerald E. Hanks(31), Eric M. Horwitz(22), Alexandra L. Hanlon(20), Deborah Watkins Bruner(7), Timothy E. Schultheiss(6), Benjamin Movsas(6), Richard E. Greenberg(6), G. Hanks(5), Alexandra L. Hanlon(5), J. D. Chapman(5), A.L. Hanlon(5), Howard M. Sandler(4), Shawn McNeeley(4), Gary M. Freedman(4), C. C. Stobbe(4), Eric A. Ross(3), Neal J. Meropol(3), Eric M. Horwitz(3), Raj Mitra(3), Himanshu Lukka(3)